Glutamate and calcium dyshomeostasis have been documented in Alzheimer’s disease; however, it has been difficult to determine whether or not calcium and glutamate phenotypes precede amyloid and tau phenotypes in humans. This evidence concerns the gene MAPT and amyloidosis.